Latest article: |
|
|
Recent articles: |
|
Tecan to Showcase Latest Range Liquid Handling Platforms, Detection Systems and OEM Components at AACC 2010
 19 Jul 2010: Visitors to the Tecan booth will be able to see liquid handling solutions for clinical applications, including a demonstration of automated front-end, pre-analytical sample handling with the FE500pro™. Also on display will be the Freedom EVOlyzer® ELISA processing workstation and the new Infinite® F50 8-channel absorbance reader for fast and reproducible ELISA measurements.
Tecan
|
BioDot to Showcase Equipment for Research and Manufacture of Diagnostic Kits at AACC 2010
 19 Jul 2010: BioDot will be highlighting its core "batch" and "in line" systems for development and manufacturing of lateral flow tests. These systems will include quantitative dispensing, laminating, cutting and assembly. In addition, BioDot will be showcasing products for Biochip and Biosensor development and manufacturing around its proprietary dispensing technology.
BioDot Inc.
|
New Assays to Offer More Comprehensive Menu for Androgen and Prostate Testing
 15 Jul 2010: A new fully automated Sex Hormone Binding Globulin (SHBG) immunoassay for testing plasma or serum samples on the ADVIA Centaur® platform has been developed by Siemens Healthcare Diagnostics.
Siemens Medical Solutions Diagnostics
|
Pittcon 2011 Announces its Annual Call for Topics Conferee Networking Sessions
15 Jul 2010: Topics must be received electronically by July 16, 2010. The Pittcon Conferee Networking Committee will review the submitted topics and selections will be completed by late August. Final session topics will be posted to the Pittcon website in October.
The Pittsburgh Conference
|
New Kits Provide Earlier Detection of Heart Damage
 13 Jul 2010: Alere International launches three improved tests for earlier detection of low levels of TnI which improves outcomes and benefits the patient. The kits are: Troponin I - a single-analyte, improved sensitivity Troponin I (TnI) test, Cardio2 - a two analyte panel consisting of the new Troponin I and BNP as well as Cardio3 - a three analyte panel consisting of the new Troponin I, BNP and CK-MB.
Alere International
|
New Quality Controls from Randox Enable Reliable Patient Results
 09 Jul 2010: Randox Laboratories announces expansion to the Acusera with the introduction of several new quality controls. The new range of Liquid controls eliminates the need for reconstitution minimising the risk of human error saving laboratories both time and money. The new lyophilised range of controls ensures a longer shelf life and stability resulting in more convenient storage at 2-8oC and easier transportation.
Randox Laboratories Ltd
|
Pittcon to Participate in International Year of Chemistry (IYC)
22 Jun 2010: Extra activities to celebrate the International Year of Chemistry (IYC) at Pittcon 2011 have been announced. The extra programs include Science Week, which will serve the city of Atlanta and surrounding clinical-diagnostics, and on a more global level, and the Technical Program, which will include sessions on how chemical research is critical for solving global problems involving food, water, health, energy and transportation.
The Pittsburgh Conference
|
Bridge4Bio Teams with Instream Partners to Focus on Investment Advice
 18 Jun 2010: Life sciences and biotechnology organizations needing to raise capital or quickly identify corporate partners or merger/acquisition candidates worldwide can now benefit from receiving sound, focused investment advice following a collaborative pact forged between Bridge4Bio, LLC and Instream Partners, a FINRA member and leading investment banking and advisory corporate financial group.
Bridge4Bio, LLC
|
Super Resolution Pioneer to Open MICROSCIENCE 2010
16 Jun 2010: Dr Jennifer Lippincott-Schwartz (NIH, US) – a pioneer of super resolution imaging - will give the opening Plenary Lecture at MICROSCIENCE 2010 in London’s docklands on Tuesday 29th June 2010.
Royal Microscopical Society
|
blood transfusion
11 Aug 2010: Randox now offers Metabolic Syndrome Arrays for the simultaneous determination of analytes associated with Metabolic Syndrome and related disorders for improved patient profiling. Individuals with Metabolic Syndrome are more likely to have a stroke, heart attack or develop type 2 diabetes.
